Company Description
Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.
The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products.
It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.
It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.
The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024.
Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
| Country | United States |
| Founded | 2022 |
| IPO Date | Feb 21, 2025 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| CEO | Prashant Patel |
Contact Details
Address: 3000 Bayport Drive, Suite 950 Tampa, Florida 33607 United States | |
| Phone | 844 203 6092 |
| Website | wellgisticshealth.com |
Stock Details
| Ticker Symbol | WGRX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.50 |
| CIK Code | 2030763 |
| CUSIP Number | 949503106 |
| ISIN Number | US9495031067 |
| Employer ID | 93-3264234 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Prashant Patel M.Sc., R.Ph. | Interim-Chief Executive Officer, President and Director |
| Srinivas Kalla | Chief Technology Officer |
| Dr. Shafaat Pirani Pharm.D. | Chief Clinical Officer |
| Nikul Panchal BCNP, R.Ph. | Chief Pharmacy Officer |
| Gerald E. Commissiong | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2026 | 8-K | Current Report |
| Apr 15, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 9, 2026 | 8-K | Current Report |
| Apr 7, 2026 | 8-K | Current Report |
| Apr 3, 2026 | DEF 14C | Filing |
| Mar 25, 2026 | PRER14C | Filing |
| Mar 25, 2026 | PRE 14C | Filing |
| Mar 20, 2026 | 10-K | Annual Report |
| Mar 11, 2026 | 8-K | Current Report |
| Mar 9, 2026 | 8-K | Current Report |